Tema Etfs LLC Sells 2,162 Shares of CME Group Inc. $CME

Tema Etfs LLC cut its holdings in CME Group Inc. (NASDAQ:CME) by 17.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,136 shares of the financial services provider’s stock after selling 2,162 shares during the period. Tema Etfs LLC’s holdings in CME Group were worth $2,768,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CME. Amundi boosted its holdings in shares of CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after purchasing an additional 385,225 shares during the last quarter. Truist Financial Corp increased its holdings in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after purchasing an additional 5,773 shares during the last quarter. Alley Investment Management Company LLC lifted its position in shares of CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock worth $7,896,000 after buying an additional 13,512 shares in the last quarter. Elevate Capital Advisors LLC lifted its position in shares of CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock worth $2,302,000 after buying an additional 3,919 shares in the last quarter. Finally, Victory Financial Group LLC boosted its stake in CME Group by 310.2% during the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after buying an additional 2,302 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Trading Up 2.8%

Shares of NASDAQ CME opened at $305.11 on Friday. CME Group Inc. has a 1-year low of $248.53 and a 1-year high of $329.16. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.03. The business’s 50 day moving average is $304.26 and its two-hundred day moving average is $282.62. The stock has a market capitalization of $109.42 billion, a P/E ratio of 27.34, a PEG ratio of 3.18 and a beta of 0.26.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.75 by $0.02. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period last year, the company earned $2.52 EPS. As a group, research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Tuesday, March 10th were given a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Tuesday, March 10th. CME Group’s dividend payout ratio is 46.59%.

Analyst Ratings Changes

Several equities analysts have weighed in on CME shares. Royal Bank Of Canada raised their price target on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a report on Thursday, February 5th. Raymond James Financial decreased their price objective on CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. UBS Group reissued a “neutral” rating and issued a $310.00 target price on shares of CME Group in a report on Friday, February 6th. Bank of America boosted their price target on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Finally, Erste Group Bank raised shares of CME Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 5th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $304.06.

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction on Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the transaction, the director directly owned 24,999 shares of the company’s stock, valued at $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. This trade represents a 31.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 8,539 shares of company stock valued at $2,713,821 over the last ninety days. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.